En esta página
01CLYM precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
CLYM Climb Bio, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$10,94
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,54mínimo 52 semanas
$18,33máximo 52 semanas
Capitalización Bursátil (MRQ)
$628M
P/E
-12.4
BPA
$-0.88
tus insignias
Rango 52S
$2–$18
Calificación del Analista
STRONG BUY
Precio Objetivo
$28
P/E
-12.4
ROE
-34.6%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
CLYM Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$10.94
Capitalización Bursátil (MRQ)
$628M
P/E
-12.4
BPA
$-0.88
ROE
-34.6%
Rango 52S
$2–$18
CLYM Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-0.882021-12-31 → 2025-12-31
Flujo de caja libre$-55M2024-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | CLYM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -12.4promedio 5A ≈-2.5 | ≈-2.5 | · | · | |
| P/C (MRQ) | 2.6promedio 5A ≈1.0 | ≈1.0 | 3.2 | Valor razonable | |
| Price / FCF (Precio / FCF) | -9.6 | · | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -9.6promedio 5A ≈-5.4 | ≈-5.4 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 3.3promedio 5A ≈1.0 | ≈1.0 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | CLYM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -31.1%promedio 5A ≈-38.4% | ≈-38.4% | -31.1% | En línea | |
| ROE | -34.6%promedio 5A ≈-32.7% | ≈-32.7% | -34.6% | En línea |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | CLYM | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 31.5promedio 5A ≈23.3 | ≈23.3 | 8.0 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 14.5promedio 5A ≈22.0 | ≈22.0 | 5.2 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-14.0%
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 18, 2026 | $-0.18 | $-0.22 | 17.4% |
| 31 de marzo de 2026 | May 19, 2026 | $-0.20 | $-0.27 | 26.5% |
| 31 de diciembre de 2025 | $-0.26 | $-0.20 | -29.4% | |
| 30 de septiembre de 2025 | $-0.19 | $-0.15 | -27.0% | |
| 30 de junio de 2025 | $-0.13 | $-0.19 | 31.1% | |
| 31 de marzo de 2025 | $-0.31 | $-0.15 | -102.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $47M | $14M | $15M | $26M | $23M | $9M | |
| SG&A Expense | $21M | $16M | $25M | $19M | $12M | $2M | |
| Operating Expenses | $68M | $82M | $40M | $45M | $36M | $21M | |
| Operating Income | $-68M | $-82M | $-40M | $-45M | $-36M | $-21M | |
| Interest Income | $8M | $8M | $5M | · | · | · | |
| Other Non-op | $8M | $8M | $5M | $-109.0K | $-12M | $257.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-60M | $-74M | $-35M | $-45M | $-47M | $-21M | |
| EPS (Basic) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · | |
| EPS (Diluted) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · | |
| Shares (Basic) | 67,812,145 | 48,163,301 | 26,987,122 | 26,311,554 | 12,260,551 | · | |
| Shares (Diluted) | 67,812,145 | 48,163,301 | 26,987,122 | 26,311,554 | 12,260,551 | 2,187,813 | |
| EBITDA | $-68M | $-82M | · | $-45M | $-36M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $36M | $87M | $93M | $44M | $47M | $20M | |
| Short-term Investments | $65M | $64M | $14M | $80M | $90M | $0 | |
| Prepaid Expense | $5M | $4M | $3M | $11M | $12M | $2M | |
| Current Assets | $106M | $155M | $110M | $134M | $148M | $22M | |
| PP&E (Net) | $288.0K | $199.0K | · | · | · | · | |
| Other Non-current Assets | $2M | $16.0K | $15.0K | $128.0K | $70.0K | $3M | |
| Total Assets | $168M | $217M | $110M | $135M | $173M | $25M | |
| Accounts Payable | $2M | $705.0K | $66.0K | $750.0K | $1M | $1M | |
| Accrued Liabilities | · | $4M | $2M | $5M | $5M | $1M | |
| Current Liabilities | $7M | $5M | $3M | $6M | $6M | $3M | |
| Capital Leases | $285.0K | $375.0K | $15.0K | $180.0K | $0 | · | |
| Other Non-current Liabilities | · | $0 | $22.0K | $0 | $7.0K | $0 | |
| Total Liabilities | $7M | $5M | $3M | $6M | $6M | $3M | |
| Common Stock | $5.0K | $7.0K | $3.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-290M | $-230M | $-156M | $-121M | $-76M | $-28M | |
| AOCI | $435.0K | $23.0K | $-2.0K | $-358.0K | $-123.0K | $0 | |
| Stockholders' Equity | $160M | $212M | $108M | $129M | $167M | $-25M | |
| Liabilities + Equity | $168M | $217M | $110M | $135M | $173M | $25M | |
| Shares Outstanding | 47,766,338 | 67,255,434 | 27,699,446 | 26,567,681 | 26,567,681 | 3,418,751 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $97.0K | $0 | · | · | · | · | |
| Stock-based Comp | $8M | $6M | $13M | $7M | $4M | $707.0K | |
| Other Non-cash | $-3M | · | · | · | · | · | |
| Operating Cash Flow | $-54M | $-16M | $-21M | $-37M | $-36M | $-14M | |
| CapEx | $186.0K | $0 | $0 | · | · | · | |
| Investing Cash Flow | $3M | $-121M | $69M | $34M | $-115M | $8M | |
| Stock Issued | · | $11M | $841.0K | $0 | $149.0K | · | |
| Net Stock Activity | · | $11M | · | · | $149.0K | · | |
| Financing Cash Flow | $-21.0K | $131M | $841.0K | $0 | $177M | $5M | |
| Net Change in Cash | $-52M | $-6M | $50M | $-3M | $26M | $-736.0K | |
| Free Cash Flow | $-55M | $-20M | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -31.1% | -45.1% | · | -29.4% | -48.0% | · | |
| ROE | -34.6% | -34.3% | · | -34.4% | -27.6% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 15.2 | 31.4 | · | 22.0 | 24.6 | · | |
| Quick Ratio | 14.5 | 30.6 | · | 20.3 | 22.6 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.36 | $3.15 | · | $4.84 | $6.37 | · | |
| Cash Flow / Share | $-0.80 | $-0.32 | · | $-1.42 | $-2.94 | · | |
| Cash / Share | $0.75 | $1.30 | · | $1.64 | $1.79 | · | |
| EPS (TTM) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-60M | $-74M | $-35M | $-45M | $-47M | · | |
| Market Cap | $191M | $121M | · | $98M | $274M | · | |
| P/E | -4.5 | -1.2 | -2.1 | -2.1 | -2.5 | · | |
| P/B | 1.2 | 0.6 | · | 0.8 | 1.6 | · | |
| P / Tangible Book | 1.2 | 0.6 | 0.7 | 0.8 | 1.6 | · | |
| P / Cash Flow | -3.5 | -7.8 | · | -2.6 | -7.6 | · | |
| P / FCF | -3.5 | -6.0 | · | · | · | · | |
| Earnings Yield | -22.0% | -85.0% | -48.1% | -46.9% | -40.5% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $10M | $9M | $14M | $9M | $7M | $17M | $6M | $6M | $1M | $1M | $3M | $3M | $4M | $6M | $5M | $4M | |
| SG&A Expense | $6M | $6M | $6M | $6M | $4M | $6M | $5M | $5M | $4M | $2M | $2M | $2M | $3M | $18M | $5M | $4M | |
| Operating Expenses | $15M | $15M | $19M | $15M | $11M | $23M | $11M | $12M | $56M | $3M | $5M | $5M | $7M | $23M | $10M | $9M | |
| Operating Income | $-15M | $-15M | $-19M | $-15M | $-11M | $-23M | $-11M | $-12M | $-56M | $-3M | $-5M | $-5M | $-7M | $-23M | $-10M | $-9M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $1M | · | · | · | · | · | · | · | |
| Other Non-op | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $-934.0K | |
| Income Tax | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-13M | $-14M | $-18M | $-13M | $-9M | $-21M | $-8M | $-9M | $-55M | $-2M | $-4M | $-4M | $-5M | $-22M | $-8M | $-10M | |
| EPS (Basic) | $-0.18 | $-0.20 | $-0.25 | $-0.19 | $-0.13 | $-0.31 | $0.47 | $-0.13 | $-1.81 | $-0.06 | $-0.12 | $-0.15 | $-0.19 | $-0.84 | $-0.48 | $-0.37 | |
| EPS (Diluted) | $-0.18 | $-0.20 | $-0.25 | $-0.19 | $-0.13 | $-0.31 | $0.47 | $-0.13 | $-1.81 | $-0.06 | $-0.12 | $-0.15 | $-0.19 | $-0.84 | $-0.48 | $-0.37 | |
| Shares (Basic) | 76,154,071 | 68,207,313 | · | 68,003,248 | 67,585,121 | 67,462,450 | · | 67,014,183 | 30,349,562 | 27,638,528 | · | 27,071,053 | 26,840,555 | 26,492,438 | · | 26,336,029 | |
| Shares (Diluted) | 76,154,071 | 68,207,313 | · | 68,003,248 | 67,585,121 | 67,462,450 | · | 67,014,183 | 30,349,562 | 27,638,528 | · | 27,071,053 | 26,840,555 | 26,492,438 | · | 26,336,029 | |
| EBITDA | $-15M | $-15M | · | $-15M | $-11M | $-23M | · | $-12M | $-56M | $-3M | · | $-5M | $-7M | $-23M | · | $-9M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $8M | $36M | $26M | $23M | $29M | $87M | $146M | $223M | $105M | $93M | $57M | $25M | $34M | $44M | $36M | |
| Short-term Investments | $139M | $101M | $65M | $61M | $62M | $69M | $64M | $47M | $0 | $0 | $14M | $50M | $77M | $75M | $80M | $87M | |
| Prepaid Expense | $4M | $4M | $5M | $4M | $3M | $2M | $4M | $4M | $3M | $4M | $3M | $5M | $12M | $11M | $11M | $11M | |
| Current Assets | $187M | $113M | $106M | $91M | $87M | $100M | $155M | $198M | $226M | $109M | $110M | $112M | $114M | $120M | $134M | $133M | |
| PP&E (Net) | $695.0K | $250.0K | $288.0K | $318.0K | $314.0K | · | $199.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $1M | $226.0K | $16.0K | $0 | $0 | $0 | $15.0K | $15.0K | $2M | $1M | $128.0K | $141.0K | |
| Total Assets | $246M | $152M | $168M | $182M | $192M | $201M | $217M | $222M | $226M | $109M | $110M | $113M | $116M | $122M | $135M | $141M | |
| Accounts Payable | $1M | $860.0K | $2M | $477.0K | $946.0K | $777.0K | $705.0K | $291.0K | $509.0K | $85.0K | $66.0K | $736.0K | $878.0K | $864.0K | $750.0K | $1M | |
| Accrued Liabilities | · | · | · | · | · | $6M | · | $3M | $3M | $3M | $2M | $2M | $2M | $4M | $5M | $4M | |
| Current Liabilities | $6M | $4M | $7M | $5M | $6M | $7M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $5M | $6M | $6M | |
| Capital Leases | $813.0K | $216.0K | $285.0K | $352.0K | $417.0K | $319.0K | $375.0K | $0 | $0 | $0 | $15.0K | $58.0K | $100.0K | $223.0K | $180.0K | $219.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | $22.0K | $34.0K | $55.0K | $87.0K | $0 | $0 | |
| Total Liabilities | $7M | $4M | $7M | $5M | $7M | $7M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $5M | $6M | $6M | |
| Common Stock | $6.0K | $5.0K | $5.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-317M | $-303M | $-290M | $-272M | $-259M | $-251M | $-230M | $-221M | $-213M | $-158M | $-156M | $-152M | $-148M | $-143M | $-121M | $-113M | |
| AOCI | $-67.0K | $157.0K | $435.0K | $469.0K | $318.0K | $286.0K | $23.0K | $201.0K | $0 | $0 | $-2.0K | $-11.0K | $-35.0K | $-95.0K | $-358.0K | $-581.0K | |
| Stockholders' Equity | $240M | $148M | $160M | $177M | $186M | $193M | $212M | $219M | $222M | $106M | $108M | $110M | $113M | $117M | $129M | $134M | |
| Liabilities + Equity | $246M | $152M | $168M | $182M | $192M | $201M | $217M | $222M | $226M | $109M | $110M | $113M | $116M | $122M | $135M | $141M | |
| Shares Outstanding | 57,436,255 | 47,768,543 | 47,766,338 | 68,184,435 | 67,764,100 | 67,575,767 | 67,255,434 | 67,223,760 | 66,785,449 | 27,723,824 | 27,699,446 | 27,466,005 | 26,994,988 | 26,973,875 | 26,567,681 | 26,567,681 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $33.0K | $38.0K | $30.0K | $29.0K | $38.0K | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $1M | $2M | $1M | $4M | $1M | $2M | $2M | $3M | $512.0K | $465.0K | $1M | $656.0K | $777.0K | $10M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $0 | $2M | $200.0K | $700.0K | $16M | · | · | |
| Other Non-cash | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-11M | $-14M | $-16M | $-12M | $-11M | $-15M | $-6M | $-8M | $-667.0K | $-2M | $-947.0K | $3M | $-8M | $-15M | $-8M | $-4M | |
| CapEx | · | · | $0 | $109.0K | · | · | $0 | $-5M | · | · | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | $-57M | $-13M | $26M | $15M | $5M | $-43M | $-53M | $-72M | $-10M | $14M | $37M | $28M | $-2M | $6M | $14M | $9M | |
| Stock Issued | · | · | · | · | · | $0 | · | $2M | $9M | $15.0K | $288.0K | $528.0K | $24.0K | $1.0K | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $15.0K | · | · | · | $1.0K | · | · | |
| Financing Cash Flow | $104M | $5.0K | $-21.0K | $0 | $0 | $0 | $41.0K | $2M | $128M | $15.0K | $288.0K | $528.0K | $24.0K | $1.0K | $0 | $0 | |
| Net Change in Cash | $36M | $-27M | $10M | $3M | $-6M | $-58M | $-59M | $-77M | $118M | $12M | $36M | $32M | $-9M | $-9M | $8M | $3M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -6.2% | -7.8% | · | -6.4% | -4.1% | -13.4% | · | -5.3% | -32.1% | -1.5% | · | -3.1% | -3.9% | -15.7% | · | -6.0% | |
| ROE | -6.3% | -8.0% | · | -6.5% | -4.2% | -13.9% | · | -5.4% | -32.8% | -1.5% | · | -3.2% | -4.1% | -16.4% | · | -6.2% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.5 | 27.9 | · | 18.4 | 14.1 | 14.3 | · | 57.7 | 60.4 | 37.0 | · | 38.8 | 31.6 | 24.5 | · | 21.2 | |
| Quick Ratio | 30.9 | 26.9 | · | 17.6 | 13.7 | 13.9 | · | 56.5 | 59.6 | 35.6 | · | 37.0 | 28.4 | 22.3 | · | 19.5 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.17 | $3.10 | · | $2.60 | $2.74 | $2.86 | · | $3.25 | $3.33 | $3.84 | · | $4.00 | $4.17 | $4.33 | · | $5.06 | |
| Cash Flow / Share | · | $-0.21 | · | · | · | $-0.23 | · | · | · | $-0.07 | · | · | · | $-0.57 | · | · | |
| Cash / Share | $0.77 | $0.17 | · | $0.38 | $0.33 | $0.43 | · | $2.17 | $3.34 | $3.79 | · | $2.09 | $0.94 | $1.28 | · | $1.35 | |
| EPS (TTM) | $-0.82 | $-0.77 | · | $-0.16 | $-0.10 | $-1.78 | · | $-2.12 | $-2.14 | $-0.52 | · | $-1.66 | $-1.88 | $-2.06 | · | $0.01 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-58M | $-53M | · | $-51M | $-47M | $-93M | · | $-69M | $-64M | $-15M | · | $-39M | $-45M | $-54M | · | $-48M | |
| Market Cap | $749M | $327M | · | $137M | $84M | $82M | · | $342M | $475M | $76M | · | $72M | $76M | $78M | · | $86M | |
| P/E | -15.9 | -8.9 | · | -12.6 | -12.4 | -0.7 | · | -2.4 | -3.3 | -5.3 | · | -1.6 | -1.5 | -1.4 | · | 323.0 | |
| P/B | 3.1 | 2.2 | · | 0.8 | 0.5 | 0.4 | · | 1.6 | 2.1 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | |
| P / Tangible Book | 3.1 | 2.2 | · | 0.8 | 0.5 | 0.4 | · | 1.6 | 2.1 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | |
| P / Cash Flow | · | -22.8 | · | · | · | -5.3 | · | · | · | -41.8 | · | · | · | -5.2 | · | · | |
| Earnings Yield | -6.3% | -11.2% | · | -8.0% | -8.1% | -145.9% | · | -41.6% | -30.1% | -19.0% | · | -63.1% | -67.1% | -71.0% | · | 0.31% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-60M | $-74M | $-35M | $-45M | $-47M |
| EPS Diluido | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 15.2 | 31.4 | · | 22.0 | 24.6 |
| Ratio Rápido | 14.5 | 30.6 | · | 20.3 | 22.6 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-55M | $-20M | · | · | · |
Propietarios institucionales (13F) 116 declarantes · $682.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
116
Valor en tenencia
$682.3M
Nuevas posiciones
52
Posiciones cerradas
22
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 52 (+22 vs trimestre anterior) | 22 (+14 vs trimestre anterior) | 32 (+8 vs trimestre anterior) | 19 (-4 vs trimestre anterior) | +24.0M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $115 026 714 | 8 821 067 | 16,86% | Acciones |
| FMR LLC | $88 546 347 | 6 790 364 | 12,98% | Acciones |
| UBS Group AG | $44 399 453 | 3 404 866 | 6,51% | Acciones |
| BRAIDWELL LP | $36 477 770 | 2 797 375 | 5,35% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $32 678 240 | 2 506 000 | 4,79% | Acciones |
| BlackRock, Inc. | $30 707 531 | 2 354 872 | 4,50% | Acciones |
| Cormorant Asset Management, LP | $27 462 240 | 2 106 000 | 4,02% | Acciones |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $25 284 808 | 1 939 019 | 3,71% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $22 150 448 | 1 698 654 | 3,25% | Acciones |
| Woodline Partners LP | $20 633 075 | 1 582 291 | 3,02% | Acciones |
| CITADEL ADVISORS LLC | $16 925 555 | 1 297 972 | 2,48% | Acciones |
| Redmile Group, LLC | $15 991 343 | 1 226 330 | 2,34% | Acciones |
| GREAT POINT PARTNERS LLC | $13 040 000 | 1 000 000 | 1,91% | Acciones |
| Affinity Asset Advisors, LLC | $12 674 880 | 972 000 | 1,86% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $11 842 902 | 908 198 | 1,74% | Acciones |
| ADAR1 Capital Management, LLC | $10 727 343 | 822 649 | 1,57% | Acciones |
| Driehaus Capital Management LLC | $10 301 600 | 790 000 | 1,51% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $10 202 039 | 782 199 | 1,50% | Acciones |
| STEMPOINT CAPITAL LP | $9 685 395 | 742 745 | 1,42% | Acciones |
| STATE STREET CORP | $8 955 507 | 686 772 | 1,31% | Acciones |
| AMERIPRISE FINANCIAL INC | $8 579 978 | 657 971 | 1,26% | Acciones |
| Parkman Healthcare Partners LLC | $7 347 831 | 563 484 | 1,08% | Acciones |
| SUPERSTRING CAPITAL MANAGEMENT LP | $6 794 909 | 521 082 | 1,00% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $6 308 061 | 483 747 | 0,92% | Acciones |
| VANGUARD GROUP INC | $5 362 016 | 1 340 504 | 0,79% | Acciones |
| Invesco Ltd. | $4 869 724 | 373 445 | 0,71% | Acciones |
| MORGAN STANLEY | $4 760 747 | 365 088 | 0,70% | Acciones |
| NAN FUNG TRINITY (HK) LTD | $4 702 928 | 360 654 | 0,69% | Acciones |
| NORTHERN TRUST CORP | $4 306 981 | 330 290 | 0,63% | Acciones |
| Ikarian Capital, LLC | $3 912 000 | 300 000 | 0,57% | Acciones |
| TD Asset Management Inc | $3 483 010 | 267 102 | 0,51% | Acciones |
| Qube Research & Technologies Ltd | $3 477 103 | 266 649 | 0,51% | Acciones |
| Ally Bridge Group (NY) LLC | $3 249 203 | 249 172 | 0,48% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3 125 127 | 239 657 | 0,46% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $3 123 319 | 239 451 | 0,46% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 543 335 | 195 041 | 0,37% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $2 512 808 | 192 700 | 0,37% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $2 381 691 | 182 645 | 0,35% | Acciones |
| FIFTH THIRD BANCORP | $2 150 596 | 164 923 | 0,32% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2 147 844 | 164 712 | 0,31% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 933 024 | 148 238 | 0,28% | Acciones |
| JANE STREET GROUP, LLC | $1 718 163 | 131 761 | 0,25% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1 699 112 | 130 300 | 0,25% | Acciones |
| ArchPoint Investors | $1 680 856 | 128 900 | 0,25% | Acciones |
| Schonfeld Strategic Advisors LLC | $1 644 838 | 126 138 | 0,24% | Acciones |
| Bank of New York Mellon Corp | $1 612 501 | 123 658 | 0,24% | Acciones |
| KOTLER KEVIN | $1 600 000 | 400 000 | 0,23% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 364 427 | 104 634 | 0,20% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 262 364 | 96 807 | 0,19% | Acciones |
| Nuveen, LLC | $1 120 592 | 85 935 | 0,16% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P., RA Capital Nexus Fund III, L.P. ×11 presentaciones | 7 de julio de 2026 | 33,00% | Enmienda | Campaña de la junta directiva | SEC |
| AI ETI LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik ×6 presentaciones | 16 de octubre de 2025 | 0,00% | Enmienda | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 21 insiders · 10 directivos · 13 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Aoife Brennan | President and CEO | 27 de junio de 2026 M | 87 731 | 0 | 1 | $-406 979 |
| Robert Azelby | President & CEO | 31 de octubre de 2022 A | · | 0 | 0 | $0 |
| Susan Altschuller | Chief Financial Officer | 6 de enero de 2026 A | · | 0 | 0 | $0 |
| Erin Lavelle | COO & CFO | 31 de octubre de 2022 A | · | 0 | 0 | $0 |
| Brett Kaplan | Chief Operating Officer | 26 de agosto de 2024 A | · | 0 | 0 | $0 |
| Perrin Megan Wilson | Chief Business Officer | 6 de enero de 2026 A | · | 0 | 0 | $0 |
| Cindy Driscoll | Senior Vice President, Finance | 6 de enero de 2026 A | · | 0 | 0 | $0 |
| Emily Pimblett | SVP, Finance & CAO | 18 de junio de 2025 M | 18 888 | 0 | 0 | $0 |
| Valerie Morisset | EVP, R&D AND CSO | 22 de julio de 2024 S | 31 317 | 0 | 0 | $0 |
| James B Bucher | EVP and General Counsel | 31 de octubre de 2022 A | · | 0 | 0 | $0 |
| Stephen Basil Thomas | Consejero | 15 de septiembre de 2026 S | 467 969 | 0 | 5 | $-2 245 963 |
| Breanna Maurine Celebi | Consejero | 29 de junio de 2026 A | · | 0 | 0 | $0 |
| Andrew David Levin | Consejero | 5 de junio de 2026 A | · | 0 | 0 | $0 |
| Judith Dunn | Consejero | 5 de junio de 2026 A | · | 0 | 0 | $0 |
| Alexander Cumbo | Consejero | 5 de junio de 2026 A | · | 0 | 0 | $0 |
| Kimberlee C Drapkin | Consejero | 5 de junio de 2026 A | · | 0 | 0 | $0 |
| Douglas E Williams | Consejero | 5 de junio de 2026 A | · | 0 | 0 | $0 |
| Simon Tate | Consejero | 26 de junio de 2024 A | · | 0 | 0 | $0 |
| Adam Joseph Rosenberg | Consejero | 26 de junio de 2024 A | · | 0 | 0 | $0 |
| Liam Ratcliffe | Consejero | 26 de junio de 2024 A | · | 0 | 0 | $0 |
| Leone D Patterson | Consejero | 19 de mayo de 2022 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 19 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| DWAS · Invesco Exchange-Traded Fund Trust … | 1,05% | 372 681 SH | 1 de octubre de 2026 | Diario |
| VAMO · Cambria ETF Trust | 0,84% | 76 753 NS | 31 de julio de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,70% | 27 171 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,12% | 119 861 SH | 11 de septiembre de 2026 | Diario |
| FFSM · FIDELITY COVINGTON TRUST | 0,11% | 133 441 NS | 31 de julio de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 17 165 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,02% | 914 481 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,02% | 145 416 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 16 764 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 202 877 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16 698 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,01% | 76 929 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 14 520 SH | 8 de septiembre de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,00% | 8 176 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 13 817 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 292 463 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 366 686 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 917 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 195 031 SH | 11 de septiembre de 2026 | Diario |
CLYM Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 21 analistas
COMPRA
Objetivo mediano
$26.50
+142,2%
10 47,6%
Compra fuerte
10 47,6%
Compra
1 4,8%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
14 analistas · 2026-09-20Objetivo medio $27.57 +152,0%
← Por Debajo de Todos los Objetivos
Precio Actual $10.94
Mín$18.00
Media$27.57
Máx$40.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| CTMX | $725M | · | -44.8% | -22.8% | -15.9% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026